Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study.

10/11/2020
/ Publications
/
Hypofractionation
Survival

22 patients with T1 to T2 N0M0 NSCLC received image-guided hypofractionated PBT to a total dose 48 GyRBE in 4 fractions for peripheral lesions and 60 GyRBE in...

Active-Scanned Protons and Carbon Ions in Cancer Treatment of Patients With Cardiac Implantable Electronic Devices: Experience of a Single Institution.

08/08/2019
/ Publications

A study by Heidelberg group looked into if ionizing radiation influenced the function of cardiac implantable electronic devices (CIED's) leading to malfunctions...

Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.

07/10/2019
/ Publications

Six hundred sixty-nine patients with 682 tumors with histologically or clinically diagnosed Stage I NSCLC who received passive-scattering PBT in Japan were...

Proton therapy for locally advanced NSCLC

10/10/2019
/ Publications

A review article by MD Anderson group. Using particle-beam therapy rather than photons offers the potential for further advantages because of the unique depth...

Clinical Results of Proton Beam Therapy for Esophageal Cancer

07/07/2019
/ Publications

A large retrospective study of 202 patients (90 inoperable patients and 100 patients (49.5%) had stage III/IV cancer) who were treated with PBT in Japan. This...

Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced NSCLC patients treated with concurrent chemoradiotherapy

03/06/2019
/ Publications

This study evaluated pre-treatment and post-treatment F-FDG PET/CT of 18 locally advanced NSCLC patients treated with definitive photon or proton RT. In nine...

Hypofractionated PBT for centrally located lung cancer.

03/05/2019
/ Publications
/
Hypofractionation

This study from Japan reported outcomes of 39 patients who received hypofractionated PBT for centrally located cT1-2N0M0. Twenty-four patients (62%) were...

Clinical outcomes after IMPT with concurrent chemotherapy for inoperable NSCLC.

03/04/2019
/ Publications
/
Chemotherapy

Published in the Green Journal, this study by MD Anderson reported disease control, survival, and toxicity in patients with advanced inoperable non-small cell...

Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.

10/10/2020
/ Publications
/
Toxicity
IMPT

This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...

PBT is a safe and feasible treatment for patients with second primary lung cancer after lung resection.

10/12/2018
/ Publications

A study from Japan reported 19 patients who were diagnosed with second primary lung cancer after lung resection, underwent PBT. This study reported the three...